International Conference on Autoimmunity and Transplantation (ICAT)
Goa, India | 12-16 October 2014

Click Here to Register Today!


Conference Sponsors:



  • Genetics of autoimmunity and transplantation
  • Innate immunity and autoimmunity
  • T cells and cytokines in autoimmunity and transplant rejection
  • Antibody in autoimmunity and transplant rejection
  • Complement in autoimmunity and transplant rejection
  • T and B cell regulators in autoimmunity and transplantation
  • Immune tolerance in transplantation and autoimmunity
  • Antigen specific T and B cells in autoimmunity
  • Immunopathogenesis of myasthenia gravis and other autoimmune diseases
  • Role of thymus in Myasthenia Gravis and other autoimmune diseases
  • MuSK in MG pathogenesis (workshop)
  • miRNA’s in autoimmunity
  • Prognostic/diagnostic markers in autoimmunity
  • Bone marrow transplantation immunology
  • Graft-versus-host disease
  • The Immunology of allogeneic transplantation
  • Immunopathology of graft rejection
  • Cell transplantation
  • Immunology and organ transplantation
  • Myosin in experimental heart transplantation
  • Chemokine receptors and transplantation
  • Tissue differences in clinical transplantation
  • Anti-CD 20 in autoimmunity and transplantation (workshop)
  • IV Ig in Autoimmunity and Transplantation
  • Stem cell therapy in autoimmunity
  • Complement inhibitors in the therapy autoimmunity and transplantation
  • Novel therapy for autoimmune diseases and to prevent graft rejection
  • Complement inhibitors in the therapy of autoimmunity and transplantation
  • Novel therapy for autoimmune diseases and to prevent graft rejection


Symposia speakers* and titles:

Innate immunity
Eric Gershwin, USA:  Autoimmunity and the Environment
Yehida Shoenfeld, Israel: The mosaic of autoimmunity – harnessing infections in autoimmunity

Chella David, USA: Role of HLA Class II genes in Autoimmune Diseases
Thalachallour Mohanakumar, USA: Interplay between Immune responses to HLA and Non-HLA self-antigens in allograft rejection

Antigen Targets
Monica Zwierzchoniewska, UK: Myosin in experimental heart transplantation
Rickard Holmdahl, Sweden: Autoimmunity to post translational modifications
Vijay Kuchroo, USA: Unexpected targets and triggers of tissue inflammation
Hartmut Wekerle, Germany: Origins of brain autoimmunity: Triggering and expansion

Narinder Mehra, India: HLA and non HLA antibodies in transplantation – the way forward
Gavin Pettigrew, UK: Donor lymphocyte chimerism and autoantibody development in recipients of solid organ allografts
Angela Vincent, UK: CNS diseases with autoantibodies to ion channels, receptors or associated protein
Chandra Mohan, USA: Viewing LUPUS through the OMICS lens
Kathryn Wood, UK: Regulatory Cells- from mechanisms to medicine
Sonia Berrih-Aknin, France: Defects of Immune regulation in myasthenia gravis

Roberto Furlan, Italy: Microglial microvesicles in autoimmune neuroinflammation
Michal Schwartz , Israel: Protective autoimmune network in the resolution of neuroinflammation:Orchestrated trafficking of inflammation-resolving leukocytes through the brain’s choroid plexus

Novel Therapies
Zaal Kokaia, Sweden: Stroke and stem cells – inflammation matters
Pavan Reddy, USA: Biology and novel therapies for GVHD.
Srini Kaveri, France: The effect of immunoglobulin therapy in autoimmunity and antibody mediated graft rejection
Razzaque Ahmed, USA: Use of biologic agents produces long-term remissions in pemphigus and pemphigoid
Premkumar Christadoss, USA: Complement C2 siRNA therapy for MG and other complement mediated autoimmune diseases
Reinhard Hohlfeld, Germany: The evolution of Multiple Sclerosis therapeutics: a (partial) success story

MusK myasthenia gravis (workshop)
Selected from submitted abstract

Anti-CD20 therapy (workshop)
Selected from submitted abstract

*accepted invitation